Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Feb 12, 2009


Gentel Biosciences last week announced the promotion of G Randall Durnell to executive vice president and COO, and the hiring of Dan Clutter as vice president of commercial development.

Durnell joined Gentel a year ago and had been VP of commercial operations. In his new position, he will be responsible for all aspects of Gentel’s commercial operations including manufacturing and corporate development.

Clutter, who will report to Durnell, will be responsible for sales, marketing, and product commercialization. Clutter has held sales, marketing, and business development positions at PerkinElmer, Invitrogen, Roche, Celera, PanVera, Asterand, and NimbleGen.

Microarray firm Aushon BioSystems this week appointed Joseph Blanchard as COO.

Blanchard has more than 20 years of leadership experience in life sciences, and had been at Decision Biomarkers where he was senior vice president of business development and strategy.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.